Hyperuricaemia and gout in cardiovascular, metabolic and kidney disease.

In conclusion, uric acid is emerging as a potentially treatable risk factor for cardiometabolic diseases, and more clinical trials investigating the potential benefit of lowering serum uric acid are recommended in individuals with hyperuricaemia with and without deposition and concomitant hypertension, metabolic syndrome or chronic kidney disease.
PMID: 32739239 [PubMed - as supplied by publisher]

Source: European Journal of Internal Medicine - July 28, 2020 Category: Internal Medicine Authors: Borghi C, Agabiti-Rosei E, Johnson RJ, Kielstein JT, Lurbe E, Mancia G, Redon J, Stack AG, Tsioufis KP Tags: Eur J Intern Med Source Type: research